Cell therapy has tremendous clinical potential and is rapidly expanding to new and diverse indications and modalities. However, the design of many of today’s cell therapies is confined and suboptimal. At Sollus Therapeutics, we are building next-generation cell therapies that address these limitations using our best-in-class platform for the systematic optimization of immune cell function. We combine synthetic biology, gene editing, protein engineering, and high-throughput screening to design enhanced immune cells specifically tailored for the indication and modality – bringing better cell therapies to more patients.